<?xml version="1.0" encoding="UTF-8"?>
<ref id="B63">
 <label>63.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tapia</surname>
    <given-names>MD</given-names>
   </name>
   <name>
    <surname>Sow</surname>
    <given-names>SO</given-names>
   </name>
   <name>
    <surname>Lyke</surname>
    <given-names>KE</given-names>
   </name>
   <name>
    <surname>Haidara</surname>
    <given-names>FC</given-names>
   </name>
   <name>
    <surname>Diallo</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Doumbia</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial</article-title>. 
  <source>Lancet Infect Dis.</source> (
  <year>2016</year>) 
  <volume>16</volume>:
  <fpage>31</fpage>â€“
  <lpage>42</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1473-3099(15)00362-X</pub-id>
  <?supplied-pmid 26546548?>
  <pub-id pub-id-type="pmid">26546548</pub-id>
 </mixed-citation>
</ref>
